Nordic Nanovector (Norway)

Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting 227Th-DOTA-p-benzyl-trastuzumab

Helèn Heyerdahl, Nasir Abbas, Ellen Mengshoel Brevik et al. · PLoS ONE · 2012 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Preparation of 212 Pb-labeled monoclonal antibody using a novel 224 Ra-based generator solution

Sara Westrøm, Roman Generalov, Tina Bjørnlund Bønsdorff et al. · Nuclear Medicine and Biology · 2017 · 50 citations · Full text

Pharmacy, Molecular Pharmaceutics, Nuclear Medicine +17

Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

Ada H. V. Repetto‐Llamazares, Roy H. Larsen, Camilla Mollatt et al. · Current Radiopharmaceuticals · 2013 · 48 citations · Full text

Medicine, Oncology, Pharmacology +15

Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma.

Jostein Dahle, Ada H. V. Repetto‐Llamazares, Camilla Mollatt et al. · PubMed · 2013 · 45 citations

Pharmacy, Immunology, Oncology +17

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Arne Kolstad, Tim Illidge, Nils Bolstad et al. · Blood Advances · 2020 · 44 citations · Full text

Medicine, Hematology, Oncology +14